Published in:
Open Access 01-12-2016 | Erratum
Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines
Published in: Journal of Translational Medicine | Issue 1/2016
Login to get accessExcerpt
It has come the publisher’s attention that the original version of this article [1] unfortunately contained an error. In Table 3, first column, the FcγRIIA 131 H>R genotypes were incorrectly labelled. In particular, V/V should have read H/H, V/F should have read H/R and F/F should have read R/R. Please note that this correction does not change the genotype numerical values of FcγRIIA polymorphism. The correct Table 3 has been published as Table 1 in this Erratum.
Table 1
Genotypic and allelic frequencies of FcγRIIIA and FcγRIIA polymorphisms in breast cancer patients and healthy controls
|
Genotypes
|
n (%)
|
P *
|
Alleles
|
n (frequency)
|
P°
|
||||
|---|---|---|---|---|---|---|---|---|---|
|
NEO (n = 15)
|
MTS (n = 10)
|
CTR (n = 33)
|
NEO (2n = 30)
|
MTS (2n = 20)
|
CTR (2n = 66)
|
||||
|
FcγRIIIA 158V>F
|
FcγRIIIA 158V>F
|
||||||||
|
V/V
|
4 (26.7)
|
3 (30.0)
|
6 (18.2)
|
0.741
|
V
|
13 (0.43)
|
8 (0.40)
|
26 (0.39)
|
0.934
|
|
V/F
|
5 (33.3)
|
2 (20.0)
|
14 (42.4)
|
F
|
17 (0.57)
|
12 (0.60)
|
40 (0.60)
|
||
|
F/F
|
6 (40.0)
|
5 (50.0)
|
13 (39.4)
|
||||||
|
HWE
|
P = 0.213
|
P = 0.065
|
P = 0.522
|
||||||
|
FcγRIIA 131H>R
|
FcγRIIA 131H>R
|
||||||||
|
H/H
|
3 (20.0)
|
4 (40.0)
|
9 (27.3)
|
0.499
|
H
|
14 (0.47)
|
10 (0.50)
|
35 (0.53)
|
0.843
|
|
H/R
|
8 (53.3)
|
2 (20.0)
|
17 (51.5)
|
R
|
16 (0.53)
|
10 (0.50)
|
31 (0.47)
|
||
|
R/R
|
4 (26.7)
|
4 (40.0)
|
7 (21.2)
|
||||||
|
HWE
|
P = 0.782
|
P = 0.058
|
P = 0.845
|
||||||